Matt Shanahan (Waterford, Independent)
Link to this: Individually | In context | Oireachtas source

694. To ask the Minister for Health the downstream and overall cost-benefit analysis conducted by the corporate pharmaceutical unit when assessing reimbursement applications for novel and generic drug applications; his views on whether the full system savings are being considered in such applications; if evidence of same in action can be demonstrated; and if he will make a statement on the matter. [39906/20]

Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

The Health Service Executive has operational responsibility for medicines expenditure, thus the matter has been referred to the HSE for their attention and direct reply to the Deputy.